Individual risk of post-ivermectin serious adverse events in subjects infected with Loa loa-Reference-Cited by-同舟云学术

Individual risk of post-ivermectin serious adverse events in subjects infected with Loa loa

Published:2020-11 Issue: Volume:28 Page:100582
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Chesnais Cédric B.,Pion Sébastien D.,Boullé Charlotte,Gardon Jacques,Gardon-Wendel Nathalie,Fokom-Domgue Joël,Kamgno Joseph,Boussinesq Michel

Funder

Institut de Recherche pour le Développement

United Nations Development Programme

Bill and Melinda Gates Foundation

World Health Organization

World Bank Group

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection;Gardon;Lancet,1997

2. A test-and-not-treat strategy for onchocerciasis in Loa loa-endemic areas;Kamgno;N Engl J Med,2017

3. Alternative treatment strategies to accelerate the elimination of onchocerciasis;Boussinesq;Int Health,2018

4. A test-and-not-treat strategy for onchocerciasis elimination in Loa loa co-endemic areas: cost analysis of a pilot in the Soa health district, Cameroon;Lenk;Clin Infect Dis,2019

5. World Health Organization. Report of the second Meeting of the WHO Onchocerciasis Technical Advisory Subgroup, WHO, Geneva, Switzerland, 12-14 February 2018. WHO/CDS/NTD/PCT/2018.11. 2018 https://apps.who.int/iris/bitstream/handle/10665/277238/WHO-CDS-NTD-PCT-2018.11-eng.pdf.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting;PLOS Neglected Tropical Diseases;2024-05-21

2. Safety and Short-term Efficacy of a Single Dose of 2 mg Moxidectin in Loa loa–Infected Individuals: A Double-Blind, Randomized Ivermectin-Controlled Trial With Ascending Microfilarial Densities;Open Forum Infectious Diseases;2024-04-25

3. Topical Dexamethasone Counters Intravitreal Ivermectin-Induced Ocular Toxicity in a Rabbit Model;Current Eye Research;2024-03-19

4. Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia;Parasites & Vectors;2024-03-15

5. The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasis;The Lancet Infectious Diseases;2023-10